Hospitalisation for acute heart failure (AHF) is associated with high mortality and high
rehospitalisation rates. In the absence of evidence-based therapy, treatment is aimed at …

Hypokalaemia is common in patients with cardiovascular disease. In this review, we
emphasize the importance of tight potassium regulation in patients with cardiovascular …

Aims Guidelines recommend down‐titration of loop diuretics (LD) once euvolaemia is
achieved. In outpatients with heart failure (HF), we investigated LD dose changes in daily …

Aims Decongestion strategies for acute decompensated heart failure (ADHF) characterized
by volume overload differ widely. The aim of this independent international academic web …

Aims To assess the proportion of patients with heart failure and reduced ejection fraction
(HFrEF) who are eligible for sacubitril/valsartan (LCZ696) based on the European Medicines …

Heart failure (HF) is a chronic debilitating and potentially life-threatening condition. HF
patients are usually at high risk of polypharmacy and consequently, potentially inappropriate …

Heart failure (HF) is a condition at high risk for orthostatic hypotension (OH) given the large
proportion of patients at an advanced age and high burden of comorbidities contributing to …

Background India has one of the largest population of heart failure (HF) patients in the world;
yet only limited information is available about HF in India. Methods This observational study …

The proportion of the elderly population continues to increase due to the global increase in
longevity. Heart failure with preserved ejection fraction (HFpEF) is common in the elderly …

There is ongoing controversy regarding the association between loop diuretics (LD),
especially in high doses, and adverse clinical outcomes in outpatients with heart failure …